Add to Favorites

Health Care Databases

With over 18 years’ experience in China healthcare industry, Loudon China has built up a robust database. This database covers the incidence of new patients per year and the prevalence of all patients living currently with several key diseases in China.
For a stakeholder to enter into a new therapeutic area or to launch new products or new indications for old products, it is in most situations of key importance to get a comprehensive first-look at any disease and its patients’ dynamics and locations.
Loudon’s databases identify eligible patient populations, disease dynamics and evolution. Product portfolios and city segments can be prioritized, go/no-go criteria defined, competition assessed and unmet needs in the market place identified.



*If any questions, please contact our client service person.

 

James Th. Loudon

Tel: +86-15221018640

Email: loudon@loudon-research.com

 

Mark Wagstaff

Tel: +86-13501764474

Email: mark.wagstaff@loudon-research.com


abbvie

Actelion

AGFA

astellas

AZ


B+L

Baxter

Bayer

BCG

BD

BI


BMS


Cephalon

Cocacola

COVIDIEN

中信国健

Credit Suisse

EBEWE

Eisai

GSK

Heineken


HELSINN


IPSEN

JJMC

凯利泰

Kowa

Bago

Lilly
McKinsey

Medtronic

MSD

Novartis

Novo nordisk

Optimer

Pfizer

ProMexico

Roche


Sandoz


Sanofi

中美史克
Sumitomo
Takeda


Techpool


Warburg pincus


XJP